The Latest Life Sciences Tools & Diagnostics Articles from Streetwise Reports


Co-Diagnostics Utilizes CoPrimer Platform to Design New Coronavirus Detection Test

  ()
Molecular diagnostics company Co-Diagnostics' shares opened more than 144% higher after the firm reported it has designed a test for virus detection of the new coronavirus, 2019-nCoV, using its CoPrimer™ platform. read more >

Disruptive Technology Poised to Deliver Significant Advancement in Bladder Cancer Detection

Contributed Opinion
  ()
Chris Temple, editor and publisher of The National Investor, explains why he recommends this small-cap as a Buy. read more >

Two Analysts See Company as a Buy for 'Game-Changing' Potential in Bladder Cancer Detection and Surgery

  ()
The disruptive technology is 'poised to deliver significant advancement in bladder cancer detection.' read more >

Transenterix Shares Trade Up 25% on FDA Filing for First Machine Vision System in Robotic Surgery

  ()
Shares of Transenterix opened 50% higher after the company reported that it has submitted a 510(k) submission to the FDA for the first machine vision system for use in robotic surgery. read more >

Adaptimmune Shares Triple as SPEAR T-cell Platform Delivers Initial Responses in Four Solid Tumor Indications

  ()
Shares of Adaptimmune Therapeutics more than tripled in value after the company reported that its SPEAR T-cell platform delivered positive initial responses in four different solid tumor indications. read more >
News Update

Developer Completes Design Verification of Imaging Device for Bladder Cancer

News Update
  ()
In doing so, it gets one step closer to market approval from U.S. regulators. read more >

Microbot Shares Soar on Claims It Has Created the World's First Fully Disposable Endovascular Robotic System

  ()
Shares of Microbot Medical traded 70% higher after the company reported that in January 2020 it will unveil the world's first fully disposable robotic system for endovascular procedures. The firm claims that its breakthrough technology features compact design, remote operation capabilities and an integrated "One & Done" tool to democratize endovascular procedures. read more >

Reliq Re-establishes Itself as Community Care Technology Leader Amidst Sweeping Federal Medicare/Medicaid Changes

Contributed Opinion
  ()
A shift in the industry leads to big new contracts and parabolic stock performance for this small cap. read more >

Castle Biosciences Shares Storm Higher After Quadrupling Q3 YoY Revenue

  ()
Shares of melanoma and other skin cancers diagnostic firm Castle Biosciences Inc. traded more than 15% higher after the firm announced Q3/19 financial and operational results. read more >

Dexcom Posts 49% YoY Revenue Growth, Sending Shares to 52-Week High

  ()
Glucose monitoring systems developer Dexcom's shares traded 30% higher after releasing Q3/19 earnings and raising full-year 2019 guidance. read more >

Fulgent Genetics Hits 52-Week High After Posting 84% Q3 Revenue Increase

  ()
Fulgent Genetics shares traded more than 40% higher after the company reported record revenue in Q3/19. The firm noted that it completed a record 20,697 billable tests in the quarter, up 272% over the same period last year. read more >

Navidea Shares Jump 60% on Phase 2b Rheumatoid Arthritis Trial Results

  ()
Shares of Navidea Biopharmaceuticals traded greatly higher on extremely high relative volume after the firm released data from its Phase 2b Rheumatoid Arthritis Tc 99m Tilmanocept Planar Imaging study. read more >

New Data Could Drive Use of Pancreatic Cancer Early Detection Test

Research Report
  ()
The recent results and their implications are provided in an H.C. Wainwright & Co. report. read more >

Technical Analyst Expects Health Technologies Firm to Break Higher

Contributed Opinion
  ()
Technical analyst Clive Maund outlines the reasons this stock might break higher. read more >

Guardant Health Reports Quarterly Revenue Up 178%

  ()
Guardant Health Inc. reported strong growth for Q2/19 versus the same period last year and raised its full-year 2019 revenue guidance to $180–190 million. read more >

Biotech's Mosquito Test 'Gains Market Acceptance'

Research Report
  ()
This West Nile virus test and others including cancer diagnostic tests in the Utah company's pipeline are discussed in an H.C. Wainwright & Co. report. read more >

Tandem Increases Unit Sales of t:slim X2 Insulin Pumps 290% Worldwide

  ()
Tandem Diabetes Care's second quarter earnings highlighted a 290% increase in unit sales of its t:slim X2 insulin pumps that feature integrated continuous glucose monitoring and remote software update capability. read more >
Showing Results: 1 to 17 of 17

Get Our Streetwise Reports Life Sciences Report Newsletter Free and be the first to know!

A valid email address is required to subscribe

More Experts

"From a stock perspective, 2019 was a clear breakout year for DRRX." ❭
– Ed Arce, H.C. Wainwright & Co.